ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1,2,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
2,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
2,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3,1,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
3,2,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
4,1,Duodenal ulcer,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
4,2,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
5,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
5,2,Delirium,Deliria,Deliria (incl confusion),Psych,N
5,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
5,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
6,1,Blindness transient,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
7,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
8,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
8,2,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
8,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
9,1,Pancreatic carcinoma,Pancreatic neoplasms malignant (excl islet cell and carcinoid),Gastrointestinal neoplasms malignant and unspecified,Neopl,N
10,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
11,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
12,1,Sinus node dysfunction,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
13,1,Uterine polyp,Uterine neoplasms,"Uterine, pelvic and broad ligament disorders",Repro,N
13,2,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
14,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
15,1,Rhinitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
16,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
17,1,Inappropriate affect,Affect alterations NEC,Mood disorders and disturbances NEC,Psych,N
18,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
18,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
18,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
19,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
19,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
20,1,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
21,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
21,2,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
21,3,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
21,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
22,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
22,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
22,3,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
23,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
23,2,"Hallucination, auditory",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
24,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
24,2,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
25,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
25,2,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
26,1,Duodenal ulcer,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
26,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
27,1,Duodenal ulcer haemorrhage,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
28,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
28,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
28,3,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
28,4,Headache,Headaches NEC,Headaches,Nerv,N
29,1,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
30,1,Penile ulceration,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
31,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
32,1,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
33,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
33,2,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
34,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
35,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
35,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
36,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
36,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
36,3,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
37,1,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
38,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
39,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
40,1,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
40,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
41,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
42,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
43,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
43,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
43,3,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
43,4,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
43,5,Paranoid personality disorder,Personality disorders with eccentric behaviour (Cluster A),Personality disorders and disturbances in behaviour,Psych,N
43,6,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
44,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
44,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
45,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
45,2,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
45,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
46,1,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
47,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
47,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
47,3,Headache,Headaches NEC,Headaches,Nerv,N
47,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
48,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
48,2,Arrhythmia supraventricular,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
48,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
48,4,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
49,1,Brief psychotic disorder with marked stressors,Brief psychotic disorder,Schizophrenia and other psychotic disorders,Psych,N
50,1,Dementia,Dementia (excl Alzheimer's type),Mental impairment disorders,Nerv,N
51,1,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
52,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
52,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
53,1,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
53,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
53,3,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
54,1,Petit mal epilepsy,Absence seizures,Seizures (incl subtypes),Nerv,N
54,2,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
55,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
55,2,Social avoidant behaviour,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
56,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
56,2,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
56,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
56,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
56,5,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
57,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
57,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
58,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
58,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
59,1,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
60,1,Atrioventricular block,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
61,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
62,1,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
63,1,Bundle branch block right,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
64,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
64,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
65,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
65,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
65,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
65,4,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
66,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
67,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
67,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
68,1,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
69,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
69,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
70,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
70,2,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
71,1,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
71,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
72,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
73,1,Peptic ulcer perforation,Peptic ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,Y
74,1,Chorea,Choreiform movements,Movement disorders (incl parkinsonism),Nerv,N
74,2,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
74,3,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
74,4,Headache,Headaches NEC,Headaches,Nerv,N
75,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
76,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
76,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
76,3,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
77,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
77,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
78,1,Atrioventricular block second degree,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
79,1,Sudden death,Death and sudden death,Fatal outcomes,Genrl,Y
80,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
81,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
81,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
81,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
82,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
83,1,Headache,Headaches NEC,Headaches,Nerv,N
84,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
84,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
84,3,Sensory loss,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
84,4,Spinal pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
85,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
86,1,Urinary retention,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
87,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
88,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
88,2,Faeces discoloured,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
88,3,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
88,4,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
89,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
90,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
90,2,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
90,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
90,4,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
91,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
91,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
91,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
91,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
92,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
92,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
92,3,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
92,4,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
93,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
93,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
93,3,Peptic ulcer,Peptic ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
93,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
93,5,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
94,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
95,1,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
96,1,Eye movement disorder,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
96,2,Respiratory arrest,Breathing abnormalities,Respiratory disorders NEC,Resp,N
96,3,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
97,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
98,1,Subarachnoid haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
99,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
100,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
101,1,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
101,2,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
102,1,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
103,1,Supraventricular tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
104,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
105,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
106,1,Delusion,Delusional symptoms,Disturbances in thinking and perception,Psych,N
106,2,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
106,3,Hypomania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
106,4,Patient elopement,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
106,5,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
107,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
107,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
107,3,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
107,4,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
107,5,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
108,1,Gastrointestinal ulcer perforation,"Gastrointestinal ulcers and perforation, site unspecified",Gastrointestinal ulceration and perforation,Gastr,N
109,1,Hiccups,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
110,1,Parkinsonism,Parkinson's disease and parkinsonism,Movement disorders (incl parkinsonism),Nerv,N
110,2,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
111,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
111,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
111,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
111,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
112,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
112,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
113,1,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
114,1,Dystonia,Dystonias,Movement disorders (incl parkinsonism),Nerv,N
115,1,Glossodynia,Tongue signs and symptoms,Tongue conditions,Gastr,N
115,2,Oral herpes,Herpes viral infections,Viral infectious disorders,Infec,N
116,1,Headache,Headaches NEC,Headaches,Nerv,N
116,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
117,1,Cystitis,Urinary tract infections,Infections - pathogen unspecified,Infec,N
118,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
118,2,Headache,Headaches NEC,Headaches,Nerv,N
118,3,Panic reaction,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
118,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
118,5,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
119,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
119,2,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
119,3,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
119,4,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
120,1,Atrioventricular block complete,Cardiac conduction disorders,Cardiac arrhythmias,Card,Y
121,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
122,1,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
122,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
122,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
123,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
123,2,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
123,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
123,4,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
123,5,Hypothermia,Body temperature altered,Body temperature conditions,Genrl,N
124,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
125,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
126,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
127,1,Cholelithiasis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
127,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
127,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
128,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
128,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
128,3,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
129,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
129,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
130,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
130,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
131,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
132,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
132,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
132,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
132,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
133,1,Atrioventricular block,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
133,2,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
134,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
135,1,Decubitus ulcer,Skin injuries and mechanical dermatoses,Epidermal and dermal conditions,Skin,N
135,2,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
135,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
135,4,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
136,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
136,2,Headache,Headaches NEC,Headaches,Nerv,N
137,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
138,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
139,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
140,1,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
141,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
141,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
142,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
142,2,Slow response to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
142,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
143,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
143,2,Cardiac failure,Heart failures NEC,Heart failures,Card,N
143,3,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
143,4,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
143,5,Hiatus hernia,Diaphragmatic hernias,Abdominal hernias and other abdominal wall conditions,Gastr,N
143,6,Oesophagitis,Oesophagitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
143,7,Pneumonia aspiration,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
143,8,Ulcer,Ulcers NEC,Tissue disorders NEC,Genrl,N
144,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
144,2,Hypersomnia,Narcolepsy and hypersomnia,Sleep disturbances (incl subtypes),Nerv,N
144,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
145,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
146,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
146,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
146,3,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
146,4,Headache,Headaches NEC,Headaches,Nerv,N
146,5,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
146,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
146,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
146,8,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
146,9,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
146,10,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
147,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
148,1,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
148,2,Extrapyramidal disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
148,3,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
149,1,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
149,2,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
149,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
149,4,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
150,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
151,1,Rhinitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
152,1,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
153,1,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
154,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
154,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
154,3,Poor quality sleep,Dyssomnias,Sleep disorders and disturbances,Psych,N
154,4,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
155,1,Gastric ulcer perforation,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
155,2,Gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
156,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
156,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
157,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
157,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
158,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
159,1,Blood bilirubin decreased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
159,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
159,3,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
159,4,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
160,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
160,2,Ventricular tachycardia,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
161,1,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
161,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
162,1,Drug level below therapeutic,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
162,2,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
162,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
162,4,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
163,1,Blood sodium increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
163,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
164,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
164,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
164,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
164,4,Sedation,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
164,5,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
165,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
165,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
166,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
167,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
168,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
169,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
170,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
170,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
170,3,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
170,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
170,5,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
170,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
170,7,Polyuria,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
170,8,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
171,1,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
171,2,Tongue coated,Tongue signs and symptoms,Tongue conditions,Gastr,N
172,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
172,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
172,3,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
173,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
174,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
175,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
175,2,Patient elopement,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
176,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
177,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
177,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
178,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
179,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
180,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
181,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
182,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
182,2,Haemorrhoids,Haemorrhoids and gastrointestinal varices (excl oesophageal),Gastrointestinal vascular conditions,Gastr,N
183,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
183,2,Faeces discoloured,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
183,3,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
184,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
184,2,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
184,3,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
184,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
185,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
186,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
187,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
188,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
189,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
190,1,Coma,Coma states,Neurological disorders NEC,Nerv,N
191,1,Chronic obstructive pulmonary disease,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,Y
192,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
193,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
194,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
195,1,Atrial flutter,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
196,1,Cerebellar haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
196,2,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
197,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
197,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
198,1,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
199,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
200,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
200,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
200,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
200,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
200,5,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
200,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
201,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
201,2,Hepatitis cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
202,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
202,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
202,3,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
203,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
203,2,Peptic ulcer perforation,Peptic ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,Y
204,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
204,2,Photopsia,Visual disorders NEC,Vision disorders,Eye,N
205,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
205,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
205,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
205,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
206,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
207,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
207,2,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
207,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
207,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
208,1,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
209,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
209,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
210,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
210,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
211,1,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
212,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
213,1,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
213,2,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
214,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
214,2,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
214,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
214,4,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
214,5,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
214,6,Sinus node dysfunction,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
214,7,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
215,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
216,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
217,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
217,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
217,3,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
218,1,Urinary retention,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
219,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
220,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
220,2,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
221,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
221,2,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
221,3,Haematochezia,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
222,1,Sudden death,Death and sudden death,Fatal outcomes,Genrl,Y
223,1,Eating disorder,Eating disorders NEC,Eating disorders and disturbances,Psych,N
223,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
223,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
224,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
224,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
224,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
224,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
225,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
226,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
227,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
227,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
227,3,Supraventricular extrasystoles,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
227,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
228,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
228,2,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
229,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
229,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
229,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
230,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
231,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
231,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
232,1,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
233,1,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
234,1,Peripheral coldness,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
235,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
235,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
235,3,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
236,1,Ventricular tachycardia,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
237,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
238,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
239,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
240,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
240,2,Erysipelas,Streptococcal infections,Bacterial infectious disorders,Infec,N
241,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
242,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
242,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
243,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
243,2,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
244,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
244,2,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
244,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
244,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
245,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
245,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
245,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
245,4,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
245,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
245,6,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
245,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
245,8,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
246,1,Gynaecomastia,Breast disorders NEC,Breast disorders,Repro,N
247,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
247,2,Sinus bradycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
247,3,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
248,1,Headache,Headaches NEC,Headaches,Nerv,N
249,1,Atrioventricular block first degree,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
249,2,Sinus bradycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
249,3,Sinus disorder,Paranasal sinus disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
249,4,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
250,1,Ejaculation delayed,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
251,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
251,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
252,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
252,2,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
252,3,Atrioventricular block complete,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
252,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
253,1,Erythema multiforme,Bullous conditions,Epidermal and dermal conditions,Skin,N
254,1,Libido increased,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
255,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
256,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
257,1,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
258,1,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
258,2,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
259,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
260,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
260,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
260,3,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
261,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
262,1,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
263,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
263,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
264,1,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
265,1,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
266,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
266,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
266,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
267,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
267,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
268,1,Conjunctival hyperaemia,"Conjunctival infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
268,2,Eyelid oedema,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
269,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
269,2,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
269,3,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
270,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
270,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
270,3,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
271,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
272,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
272,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
272,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
272,4,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
272,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
273,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
274,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
274,2,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
274,3,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
275,1,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
276,1,Clostridium difficile colitis,Clostridia infections,Bacterial infectious disorders,Infec,N
277,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
278,1,Peptic ulcer,Peptic ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
279,1,Delusion,Delusional symptoms,Disturbances in thinking and perception,Psych,N
280,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
280,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
280,3,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
280,4,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
281,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
281,2,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
282,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
282,2,Psychomotor hyperactivity,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
282,3,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
283,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
283,2,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
284,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
284,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
285,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
285,2,Anal incontinence,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
285,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
285,4,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
285,5,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
285,6,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
286,1,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
287,1,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
287,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
288,1,Middle insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
288,2,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
289,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
289,2,Delirium,Deliria,Deliria (incl confusion),Psych,N
289,3,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
290,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
290,2,Cyanopsia,Visual colour distortions,Vision disorders,Eye,N
290,3,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
290,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
291,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
291,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
291,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
291,4,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
291,5,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
291,6,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
291,7,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
292,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
292,2,Sensitive skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
293,1,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
294,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
294,2,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
294,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
295,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
295,2,Crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
295,3,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
296,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
296,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
296,3,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
296,4,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
296,5,Fluid intake reduced,Fluid intake decreased,Electrolyte and fluid balance conditions,Metab,N
296,6,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
296,7,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
296,8,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
297,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
297,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
297,3,Application site rash,Application site reactions,Administration site reactions,Genrl,N
297,4,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
297,5,Application site swelling,Application site reactions,Administration site reactions,Genrl,N
298,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
298,2,Asthenopia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
298,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
298,4,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
299,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
299,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
300,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
301,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
302,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
302,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
302,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
303,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
303,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
303,3,Dementia,Dementia (excl Alzheimer's type),Mental impairment disorders,Nerv,N
304,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
305,1,Catatonia,Decreased physical activity levels,Changes in physical activity,Psych,N
306,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
306,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
306,3,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
307,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
307,2,Skin hyperpigmentation,Hyperpigmentation disorders,Pigmentation disorders,Skin,N
308,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
308,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
309,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
309,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
310,1,Neuroleptic malignant syndrome,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
311,1,Parkinson's disease,Parkinson's disease and parkinsonism,Movement disorders (incl parkinsonism),Nerv,N
311,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
312,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
312,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
313,1,Application site scar,Application site reactions,Administration site reactions,Genrl,N
313,2,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
314,1,Faeces discoloured,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
314,2,Gastric haemorrhage,Gastric and oesophageal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
315,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
315,2,Dementia,Dementia (excl Alzheimer's type),Mental impairment disorders,Nerv,N
315,3,Dysstasia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
315,4,Incoherent,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
315,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
315,6,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
315,7,Parkinson's disease,Parkinson's disease and parkinsonism,Movement disorders (incl parkinsonism),Nerv,N
316,1,Hypertonia,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
316,2,Hypokinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
317,1,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
318,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
318,2,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
319,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
319,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
319,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
320,1,Intention tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
320,2,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
321,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
321,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
321,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
322,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
323,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
323,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
323,3,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
324,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
324,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
324,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
325,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
325,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
326,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
327,1,Application site inflammation,Application site reactions,Administration site reactions,Genrl,N
328,1,Application site irritation,Application site reactions,Administration site reactions,Genrl,N
328,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
329,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
330,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
331,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
331,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
331,3,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
332,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
333,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
333,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
334,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
334,2,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
335,1,Dermatitis bullous,Bullous conditions,Epidermal and dermal conditions,Skin,N
335,2,Skin hyperpigmentation,Hyperpigmentation disorders,Pigmentation disorders,Skin,N
336,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
336,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
337,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
338,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
338,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
338,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
339,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
339,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
339,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
340,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
341,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
342,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
342,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
342,3,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
343,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
343,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
344,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
344,2,Dermatitis bullous,Bullous conditions,Epidermal and dermal conditions,Skin,N
344,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
344,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
344,5,Pigmentation disorder,Pigmentation changes NEC,Pigmentation disorders,Skin,N
344,6,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
344,7,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
344,8,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
345,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
345,2,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
345,3,Behaviour disorder,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
345,4,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
345,5,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
346,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
347,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
348,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
348,2,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
349,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
349,2,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
350,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
350,2,Sudden death,Death and sudden death,Fatal outcomes,Genrl,Y
350,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
351,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
351,2,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
351,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
351,4,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
351,5,Eating disorder,Eating disorders NEC,Eating disorders and disturbances,Psych,N
351,6,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
351,7,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
351,8,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
352,1,Atrial flutter,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
352,2,Atrioventricular block second degree,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
352,3,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
352,4,Ventricular extrasystoles,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
353,1,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
353,2,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
354,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
354,2,Application site urticaria,Application site reactions,Administration site reactions,Genrl,N
354,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
355,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
355,2,Application site swelling,Application site reactions,Administration site reactions,Genrl,N
355,3,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
355,4,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
356,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
356,2,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
356,3,Delirium,Deliria,Deliria (incl confusion),Psych,N
356,4,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
357,1,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
357,2,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
358,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
358,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
359,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
359,2,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
359,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
359,4,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
359,5,Headache,Headaches NEC,Headaches,Nerv,N
359,6,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
359,7,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
360,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
360,2,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
360,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
360,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
361,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
361,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
362,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
362,2,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
362,3,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
362,4,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
363,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
363,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
364,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
364,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
365,1,Mental impairment,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
366,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
367,1,Oral discomfort,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
367,2,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
368,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
368,2,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
368,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
368,4,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
368,5,Patient elopement,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
369,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
369,2,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
370,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
370,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
370,3,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
371,1,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
372,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
372,2,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
373,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
373,2,Bedridden,Disability issues,Lifestyle issues,SocCi,N
373,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
373,4,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
373,5,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
373,6,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
373,7,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
373,8,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
374,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
374,2,Application site swelling,Application site reactions,Administration site reactions,Genrl,N
375,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
375,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
375,3,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
375,4,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
376,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
376,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
376,3,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
377,1,Nasal neoplasm,Paranasal sinus and nasal cavity neoplasms malignant and unspecified,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
378,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
378,2,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
379,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
379,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
380,1,Application site discomfort,Application site reactions,Administration site reactions,Genrl,N
380,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
380,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
381,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
381,2,Application site rash,Application site reactions,Administration site reactions,Genrl,N
381,3,Application site swelling,Application site reactions,Administration site reactions,Genrl,N
381,4,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
382,1,Device malfunction,Device malfunction events NEC,Device issues,Prod,N
382,2,Electrocardiogram PR prolongation,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
382,3,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
383,1,Eating disorder,Eating disorders NEC,Eating disorders and disturbances,Psych,N
384,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
384,2,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
385,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
385,2,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
386,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
387,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
387,2,Gastric ulcer haemorrhage,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
387,3,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
387,4,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
388,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
389,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
389,2,Heart rate decreased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
389,3,Hypopnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
389,4,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
390,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
390,2,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
391,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
391,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
392,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
392,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
392,3,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
392,4,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
393,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
394,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
394,2,Headache,Headaches NEC,Headaches,Nerv,N
394,3,Migraine,Migraine headaches,Headaches,Nerv,N
395,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
395,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
395,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
396,1,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
396,2,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
397,1,Akinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
397,2,Bradykinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
397,3,Extrapyramidal disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
397,4,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
398,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
398,2,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
398,3,Psychomotor hyperactivity,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
399,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
399,2,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
400,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
400,2,Cardioversion,Cardiac therapeutic procedures NEC,Cardiac therapeutic procedures,Surg,N
401,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
401,2,Dementia,Dementia (excl Alzheimer's type),Mental impairment disorders,Nerv,N
401,3,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
401,4,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
401,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
401,6,Mental impairment,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
401,7,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
401,8,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
402,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
402,2,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
403,1,Delusion,Delusional symptoms,Disturbances in thinking and perception,Psych,N
404,1,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
405,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
405,2,Application site urticaria,Application site reactions,Administration site reactions,Genrl,N
405,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
406,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
407,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
407,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
407,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
407,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
408,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
408,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
409,1,Application site dermatitis,Application site reactions,Administration site reactions,Genrl,N
409,2,Application site discolouration,Application site reactions,Administration site reactions,Genrl,N
409,3,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
409,4,Application site inflammation,Application site reactions,Administration site reactions,Genrl,N
410,1,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
411,1,Muscle rigidity,Muscle tone abnormalities,Muscle disorders,Musc,N
412,1,Faeces discoloured,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
412,2,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
412,3,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
413,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
414,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
414,2,Heart rate irregular,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
414,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
415,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
415,2,Therapeutic response unexpected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
416,1,Cystoscopy,Urinary tract imaging procedures,Renal and urinary tract investigations and urinalyses,Inv,N
416,2,Prostatic operation,Prostatic therapeutic procedures,Male genital tract therapeutic procedures,Surg,N
416,3,Urinary bladder polyp,Bladder neoplasms,Bladder and bladder neck disorders (excl calculi),Renal,N
417,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
418,1,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
418,2,Upper gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
419,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
419,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
419,3,Knee operation,Joint therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
420,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
420,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
421,1,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
421,2,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
422,1,Exophthalmos,"Structural change, deposit and degeneration of eye NEC","Ocular structural change, deposit and degeneration NEC",Eye,N
422,2,Staring,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
423,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
423,2,Heart rate irregular,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
423,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
423,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
424,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
424,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
424,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
424,4,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
425,1,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
426,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
426,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
427,1,Application site discomfort,Application site reactions,Administration site reactions,Genrl,N
427,2,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
427,3,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
427,4,Application site rash,Application site reactions,Administration site reactions,Genrl,N
427,5,Application site swelling,Application site reactions,Administration site reactions,Genrl,N
428,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
428,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
428,3,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
429,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
430,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
430,2,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
430,3,Psychomotor hyperactivity,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
431,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
432,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
432,2,Gout,Disorders of purine metabolism,Purine and pyrimidine metabolism disorders,Metab,N
433,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
434,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
434,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
434,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
435,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
435,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
435,3,Parkinson's disease,Parkinson's disease and parkinsonism,Movement disorders (incl parkinsonism),Nerv,N
436,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
437,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
438,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
438,2,Inflammation,Inflammations,General system disorders NEC,Genrl,N
438,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
439,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
440,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
440,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
440,3,Application site rash,Application site reactions,Administration site reactions,Genrl,N
440,4,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
441,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
441,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
441,3,Application site rash,Application site reactions,Administration site reactions,Genrl,N
441,4,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
441,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
442,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
442,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
443,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
443,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
443,3,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
443,4,Headache,Headaches NEC,Headaches,Nerv,N
443,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
443,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
443,7,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
444,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
444,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
444,3,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
444,4,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
444,5,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
445,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
446,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
446,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
446,3,Application site rash,Application site reactions,Administration site reactions,Genrl,N
446,4,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
446,5,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
446,6,Headache,Headaches NEC,Headaches,Nerv,N
446,7,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
447,1,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
447,2,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
448,1,Diarrhoea haemorrhagic,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
449,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
449,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
449,3,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
450,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
450,2,Application site inflammation,Application site reactions,Administration site reactions,Genrl,N
450,3,Application site irritation,Application site reactions,Administration site reactions,Genrl,N
451,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
452,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
452,2,Application site irritation,Application site reactions,Administration site reactions,Genrl,N
453,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
453,2,Application site exfoliation,Application site reactions,Administration site reactions,Genrl,N
454,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
454,2,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
455,1,Application site inflammation,Application site reactions,Administration site reactions,Genrl,N
455,2,Application site irritation,Application site reactions,Administration site reactions,Genrl,N
456,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
456,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
457,1,"Hallucination, auditory",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
457,2,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
458,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
458,2,Extrapyramidal disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
458,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
458,4,Skin laxity,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
458,5,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
459,1,Gastric ulcer,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
460,1,Glomerular filtration rate decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
461,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
462,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
463,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
463,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
463,3,Sleep terror,Parasomnias,Sleep disorders and disturbances,Psych,N
463,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
464,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
464,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
464,3,Electrocardiogram change,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
464,4,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
465,1,Application site discomfort,Application site reactions,Administration site reactions,Genrl,N
465,2,Application site pain,Application site reactions,Administration site reactions,Genrl,N
465,3,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
466,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
466,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
466,3,Application site swelling,Application site reactions,Administration site reactions,Genrl,N
467,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
467,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
467,3,Parkinson's disease,Parkinson's disease and parkinsonism,Movement disorders (incl parkinsonism),Nerv,N
467,4,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
468,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
468,2,Parkinson's disease,Parkinson's disease and parkinsonism,Movement disorders (incl parkinsonism),Nerv,N
468,3,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
469,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
470,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
471,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
472,1,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
472,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
472,3,Head injury,Site specific injuries NEC,Injuries NEC,Inj&P,N
472,4,Post-traumatic epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
472,5,Subdural haematoma,Cerebral injuries NEC,Injuries NEC,Inj&P,N
472,6,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
473,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
473,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
473,3,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
473,4,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
474,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
474,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
474,3,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
475,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
475,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
476,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
477,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
477,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
477,3,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
478,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
478,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
478,3,Lung disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
479,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
479,2,Application site inflammation,Application site reactions,Administration site reactions,Genrl,N
479,3,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
480,1,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
480,2,Myoclonus,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
480,3,Tic,Tic disorders,Changes in physical activity,Psych,N
481,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
482,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
482,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
482,3,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
483,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
484,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
485,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
485,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
486,1,Dermatitis atopic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
487,1,Dementia,Dementia (excl Alzheimer's type),Mental impairment disorders,Nerv,N
487,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
487,3,Parkinson's disease,Parkinson's disease and parkinsonism,Movement disorders (incl parkinsonism),Nerv,N
487,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
488,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
489,1,Hiccups,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
490,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
490,2,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
490,3,Mental impairment,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
491,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
492,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
493,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
494,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
495,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
496,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
497,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
497,2,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
498,1,Parkinson's disease,Parkinson's disease and parkinsonism,Movement disorders (incl parkinsonism),Nerv,N
499,1,Arrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
499,2,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
500,1,Gynaecomastia,Breast disorders NEC,Breast disorders,Repro,N
501,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
501,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
501,3,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
502,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
503,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
503,2,Application site irritation,Application site reactions,Administration site reactions,Genrl,N
503,3,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
504,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
504,2,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
504,3,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
505,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
505,2,Application site irritation,Application site reactions,Administration site reactions,Genrl,N
505,3,Application site swelling,Application site reactions,Administration site reactions,Genrl,N
506,1,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
506,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
506,3,Muscle spasticity,Neuromuscular disorders NEC,Neuromuscular disorders,Nerv,N
507,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
508,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
509,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
509,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
509,3,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
510,1,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
511,1,Gastric haemorrhage,Gastric and oesophageal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
512,1,Application site irritation,Application site reactions,Administration site reactions,Genrl,N
512,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
512,3,Dementia Alzheimer's type,Alzheimer's disease (incl subtypes),Mental impairment disorders,Nerv,N
512,4,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
512,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
513,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
514,1,Abdominal wall haemorrhage,Abdominal wall conditions NEC,Abdominal hernias and other abdominal wall conditions,Gastr,N
514,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
514,3,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
515,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
516,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
516,2,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
517,1,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
518,1,Upper limb fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
519,1,Cardiac failure,Heart failures NEC,Heart failures,Card,Y
519,2,Dementia,Dementia (excl Alzheimer's type),Mental impairment disorders,Nerv,N
520,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
520,2,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
521,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
522,1,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
522,2,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
522,3,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
522,4,Parkinson's disease,Parkinson's disease and parkinsonism,Movement disorders (incl parkinsonism),Nerv,N
522,5,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
522,6,Posture abnormal,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
522,7,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
523,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
524,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
525,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
525,2,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
525,3,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
525,4,Dementia,Dementia (excl Alzheimer's type),Mental impairment disorders,Nerv,N
525,5,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
525,6,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
525,7,Screaming,General signs and symptoms NEC,General system disorders NEC,Genrl,N
526,1,Heart rate decreased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
526,2,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
527,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
527,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
527,3,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
528,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
528,2,Extrasystoles,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
528,3,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
529,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
530,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
531,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
532,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
532,2,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
533,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
533,2,Application site pain,Application site reactions,Administration site reactions,Genrl,N
533,3,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
533,4,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
534,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
534,2,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
534,3,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
534,4,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
534,5,Salivary hypersecretion,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
534,6,Screaming,General signs and symptoms NEC,General system disorders NEC,Genrl,N
535,1,Application site irritation,Application site reactions,Administration site reactions,Genrl,N
535,2,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
535,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
535,4,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
536,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
536,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
537,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
537,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
537,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
537,4,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
537,5,Skin warm,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
537,6,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
537,7,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
538,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
538,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
538,3,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
538,4,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
539,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
540,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
541,1,Arrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
541,2,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
541,3,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
541,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
541,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
541,6,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
541,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
542,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
542,2,Open globe injury,Eye injuries NEC,Injuries NEC,Inj&P,N
543,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
543,2,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
543,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
543,4,Skin plaque,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
543,5,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
544,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
545,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
545,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
545,3,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
545,4,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
545,5,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
545,6,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
545,7,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
545,8,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
545,9,Penile infection,Male reproductive tract infections,Infections - pathogen unspecified,Infec,N
545,10,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
546,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
547,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
547,2,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
548,1,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
549,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
549,2,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
549,3,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
549,4,Upper gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
550,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
550,2,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
550,3,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
551,1,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
552,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
552,2,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
553,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
554,1,Cystitis,Urinary tract infections,Infections - pathogen unspecified,Infec,N
554,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
554,3,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
555,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
555,2,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
556,1,Application site dermatitis,Application site reactions,Administration site reactions,Genrl,N
556,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
556,3,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
557,1,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
557,2,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
558,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
558,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
558,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
559,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
559,2,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
560,1,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
561,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
561,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
561,3,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
562,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
562,2,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
563,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
563,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
563,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
563,4,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
563,5,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
564,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
565,1,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
566,1,Abnormal dreams,Parasomnias,Sleep disorders and disturbances,Psych,N
566,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
566,3,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
566,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
566,5,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
567,1,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
567,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
567,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
567,4,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
567,5,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
568,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
569,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
569,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
570,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
571,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
572,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
573,1,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
573,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
573,3,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
574,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
575,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
575,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
576,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
576,2,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
577,1,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
577,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
577,3,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
578,1,Homicidal ideation,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
579,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
579,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
579,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
579,4,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
579,5,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
579,6,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
580,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
580,2,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
580,3,Dizziness postural,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
580,4,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
580,5,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
580,6,Staring,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
580,7,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
581,1,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
582,1,Atrioventricular block complete,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
583,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
583,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
583,3,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
584,1,Application site dermatitis,Application site reactions,Administration site reactions,Genrl,N
584,2,Application site irritation,Application site reactions,Administration site reactions,Genrl,N
584,3,Application site rash,Application site reactions,Administration site reactions,Genrl,N
584,4,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
585,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
586,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
587,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
587,2,Duodenitis haemorrhagic,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
587,3,Gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
587,4,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
587,5,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
587,6,Oesophagitis,Oesophagitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
588,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
588,2,Application site irritation,Application site reactions,Administration site reactions,Genrl,N
588,3,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
588,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
588,5,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
588,6,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
589,1,Electric shock sensation,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
589,2,Sensory disturbance,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
590,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
591,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
591,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
592,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
593,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
593,2,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
593,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
593,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
594,1,Delirium,Deliria,Deliria (incl confusion),Psych,N
594,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
594,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
595,1,Diverticulum,Diverticula,Diverticular disorders,Gastr,N
595,2,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
596,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
596,2,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
597,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
597,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
597,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
597,4,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
597,5,Ventricular fibrillation,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
598,1,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
598,2,Upper gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
599,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
599,2,Personality change,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
600,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
600,2,Mania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
600,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
601,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
601,2,Parkinson's disease,Parkinson's disease and parkinsonism,Movement disorders (incl parkinsonism),Nerv,N
602,1,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
602,2,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
603,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
603,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
603,3,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
604,1,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
604,2,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
605,1,Gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
605,2,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
605,3,Infrequent bowel movements,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
605,4,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
606,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
606,2,Application site pain,Application site reactions,Administration site reactions,Genrl,N
606,3,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
606,4,Application site swelling,Application site reactions,Administration site reactions,Genrl,N
607,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
607,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
607,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
608,1,Delirium,Deliria,Deliria (incl confusion),Psych,N
608,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
608,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
609,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
609,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
610,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
611,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
611,2,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
612,1,Basal ganglion degeneration,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
612,2,Concomitant disease aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
612,3,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
612,4,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
612,5,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
612,6,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
613,1,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
614,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
614,2,Papule,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
615,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
615,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
616,1,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
616,2,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
616,3,Product residue present,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
617,1,Gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
617,2,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
617,3,Movement disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
617,4,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
618,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
618,2,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
619,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
619,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
619,3,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
620,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
620,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
620,3,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
621,1,Torticollis,Muscle tone abnormalities,Muscle disorders,Musc,N
622,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
622,2,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
623,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
624,1,Abnormal loss of weight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
624,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
624,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
624,4,Parkinsonism,Parkinson's disease and parkinsonism,Movement disorders (incl parkinsonism),Nerv,N
624,5,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
625,1,Application site haemorrhage,Application site reactions,Administration site reactions,Genrl,N
625,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
626,1,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
627,1,Pain in jaw,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
628,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
628,2,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
628,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
629,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
629,2,Application site rash,Application site reactions,Administration site reactions,Genrl,N
630,1,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
631,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
631,2,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
632,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
632,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
633,1,Sinus arrest,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
634,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
634,2,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
635,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
635,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
635,3,Product lot number issue,Product label issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
636,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
636,2,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
636,3,Eating disorder,Eating disorders NEC,Eating disorders and disturbances,Psych,N
636,4,Fluid intake reduced,Fluid intake decreased,Electrolyte and fluid balance conditions,Metab,N
636,5,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
637,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
638,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
638,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
638,3,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
639,1,Lip ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
639,2,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
639,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
639,4,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
639,5,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
640,1,Bradyarrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
640,2,Sinus bradycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
641,1,Gastric ulcer,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
641,2,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
642,1,Administration site irritation,Administration site reactions NEC,Administration site reactions,Genrl,N
642,2,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
642,3,Application site pain,Application site reactions,Administration site reactions,Genrl,N
642,4,Application site warmth,Application site reactions,Administration site reactions,Genrl,N
642,5,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
642,6,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
642,7,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
642,8,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
642,9,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
642,10,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
643,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
643,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
643,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
643,4,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
644,1,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
644,2,Rectal discharge,Anal and rectal signs and symptoms,Anal and rectal conditions NEC,Gastr,N
645,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
645,2,Application site hypersensitivity,Application site reactions,Administration site reactions,Genrl,N
645,3,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
645,4,Reaction to excipient,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
646,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
647,1,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
647,2,Myoclonus,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
648,1,Application site hypersensitivity,Application site reactions,Administration site reactions,Genrl,N
649,1,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
649,2,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
650,1,Atrial flutter,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
651,1,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
651,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
652,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
652,2,Application site rash,Application site reactions,Administration site reactions,Genrl,N
653,1,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
654,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
654,2,Dementia Alzheimer's type,Alzheimer's disease (incl subtypes),Mental impairment disorders,Nerv,N
654,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
655,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
655,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
655,3,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
655,4,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
656,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
656,2,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
657,1,Application site discolouration,Application site reactions,Administration site reactions,Genrl,N
657,2,Application site haemorrhage,Application site reactions,Administration site reactions,Genrl,N
657,3,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
658,1,Faeces discoloured,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
658,2,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
658,3,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
659,1,Migraine with aura,Migraine headaches,Headaches,Nerv,N
659,2,Scintillating scotoma,Visual disorders NEC,Vision disorders,Eye,N
660,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
661,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
661,2,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
661,3,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
661,4,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
662,1,Cholelithiasis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
662,2,Chromaturia,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
662,3,Feeding disorder,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
662,4,Hepatic infection,Hepatobiliary and spleen infections,Infections - pathogen unspecified,Infec,N
662,5,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
662,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
663,1,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
663,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
663,3,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
664,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
664,2,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
664,3,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
664,4,Hypophagia,Appetite disorders,Appetite and general nutritional disorders,Metab,N
665,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
665,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
666,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
667,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
667,2,Abnormal loss of weight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
667,3,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
667,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
668,1,Application site haemorrhage,Application site reactions,Administration site reactions,Genrl,N
668,2,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
668,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
669,1,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
670,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
671,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
671,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
672,1,Communication disorder,Communications disorders,Communication disorders and disturbances,Psych,N
672,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
672,3,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
673,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
674,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
674,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
674,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
675,1,Urinary retention,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
676,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
676,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
676,3,Faeces hard,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
676,4,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
677,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
678,1,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
678,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
678,3,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
678,4,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
678,5,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
679,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
680,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
681,1,Partial seizures,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
682,1,Application site dermatitis,Application site reactions,Administration site reactions,Genrl,N
682,2,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
683,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
683,2,Subdural haemorrhage,Cerebral injuries NEC,Injuries NEC,Inj&P,N
684,1,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
684,2,Application site rash,Application site reactions,Administration site reactions,Genrl,N
684,3,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
685,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
686,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
686,2,Application site rash,Application site reactions,Administration site reactions,Genrl,N
687,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
687,2,Application site rash,Application site reactions,Administration site reactions,Genrl,N
688,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
688,2,Application site rash,Application site reactions,Administration site reactions,Genrl,N
689,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
689,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
690,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
691,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
691,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
691,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
691,4,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
692,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
692,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
692,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
692,4,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
693,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
693,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
693,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
693,4,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
694,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
694,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
694,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
694,4,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
695,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
695,2,Parkinson's disease,Parkinson's disease and parkinsonism,Movement disorders (incl parkinsonism),Nerv,N
696,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
697,1,Blister rupture,Bullous conditions,Epidermal and dermal conditions,Skin,N
697,2,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
697,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
697,4,Immune system disorder,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
697,5,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
697,6,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
697,7,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
697,8,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
697,9,Rash vesicular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
697,10,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
698,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
698,2,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
698,3,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
698,4,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
698,5,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
698,6,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
699,1,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
699,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
699,3,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
700,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
700,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
701,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
702,1,Pneumonia aspiration,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
702,2,Salivary hypersecretion,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
703,1,Waldenstrom's macroglobulinaemia,Waldenstrom's macroglobulinaemias,Lymphomas non-Hodgkin's B-cell,Neopl,N
704,1,Application site dryness,Application site reactions,Administration site reactions,Genrl,N
704,2,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
704,3,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
704,4,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
705,1,Device issue,Device issues NEC,Device issues,Prod,N
705,2,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
705,3,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
705,4,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
706,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
706,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
707,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
708,1,Parkinson's disease,Parkinson's disease and parkinsonism,Movement disorders (incl parkinsonism),Nerv,N
709,1,Parkinson's disease,Parkinson's disease and parkinsonism,Movement disorders (incl parkinsonism),Nerv,N
710,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
710,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
710,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
711,1,Application site hypersensitivity,Application site reactions,Administration site reactions,Genrl,N
711,2,Application site rash,Application site reactions,Administration site reactions,Genrl,N
712,1,Mental impairment,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
713,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
713,2,Application site inflammation,Application site reactions,Administration site reactions,Genrl,N
713,3,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
713,4,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
713,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
713,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
713,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
714,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
714,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
714,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
714,4,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
714,5,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
714,6,Somnambulism,Parasomnias,Sleep disorders and disturbances,Psych,N
714,7,Urinary tract obstruction,Genital and urinary tract disorders NEC,Genitourinary tract disorders NEC,Renal,N
715,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
716,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
716,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
717,1,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
717,2,Ear pain,Ear disorders NEC,Aural disorders NEC,Ear,N
717,3,Headache,Headaches NEC,Headaches,Nerv,N
717,4,Pain in jaw,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
717,5,Toothache,Dental pain and sensation disorders,Dental and gingival conditions,Gastr,N
718,1,Atrioventricular block,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
718,2,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
718,3,Electrocardiogram PR prolongation,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
718,4,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
718,5,Femoral neck fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
718,6,Hip fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
718,7,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
719,1,Atrioventricular block,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
719,2,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
719,3,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
719,4,Electrocardiogram PR prolongation,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
719,5,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
719,6,Femur fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
719,7,Hip fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
719,8,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
719,9,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
720,1,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
721,1,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
721,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
721,3,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
721,4,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
721,5,Parkinson's disease,Parkinson's disease and parkinsonism,Movement disorders (incl parkinsonism),Nerv,N
722,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
722,2,Macular degeneration,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
722,3,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
723,1,Chronic kidney disease,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
723,2,Dementia,Dementia (excl Alzheimer's type),Mental impairment disorders,Nerv,N
723,3,Drooling,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
723,4,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
723,5,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
723,6,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
723,7,Near death experience,Perception disturbances NEC,Disturbances in thinking and perception,Psych,N
723,8,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
723,9,Product colour issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
723,10,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
723,11,Scratch,Skin injuries NEC,Injuries NEC,Inj&P,N
723,12,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
723,13,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
724,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
724,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
725,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
726,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
726,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
726,3,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
727,1,Non-Hodgkin's lymphoma,Non-Hodgkin's lymphomas NEC,Lymphomas non-Hodgkin's unspecified histology,Neopl,Y
727,2,Soft tissue mass,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
728,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
728,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
729,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
730,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
731,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
731,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
732,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
732,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
733,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
733,2,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
734,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
735,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
735,2,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
735,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
736,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
737,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
737,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
737,3,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
737,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
737,5,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
737,6,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
737,7,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
737,8,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
737,9,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
737,10,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
737,11,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
737,12,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
737,13,Parkinson's disease,Parkinson's disease and parkinsonism,Movement disorders (incl parkinsonism),Nerv,N
737,14,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
737,15,Salivary hypersecretion,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
738,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
738,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
738,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
739,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
739,2,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
740,1,Sexually inappropriate behaviour,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
741,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
741,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
742,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
742,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
743,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
743,2,Application site inflammation,Application site reactions,Administration site reactions,Genrl,N
743,3,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
744,1,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
744,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
745,1,Application site irritation,Application site reactions,Administration site reactions,Genrl,N
746,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
746,2,Papule,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
746,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
747,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
747,2,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
748,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
748,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
748,3,Presyncope,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
749,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
749,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
749,3,Presyncope,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
750,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
750,2,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
750,3,Morose,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
751,1,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
752,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
752,2,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
753,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
754,1,Thinking abnormal,Thinking disturbances,Disturbances in thinking and perception,Psych,N
755,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
756,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
756,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
756,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
757,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
757,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
757,3,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
757,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
758,1,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
759,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
759,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
760,1,Accidental underdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
760,2,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
760,3,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
761,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
761,2,Blood pressure fluctuation,Blood pressure disorders NEC,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
761,3,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
761,4,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
761,5,Heart rate irregular,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
761,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
761,7,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
762,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
762,2,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
762,3,Hyperkeratosis,Hyperkeratoses,Cornification and dystrophic skin disorders,Skin,N
762,4,Lichenoid keratosis,Hyperkeratoses,Cornification and dystrophic skin disorders,Skin,N
762,5,Skin oedema,Skin vascular conditions NEC,Skin vascular abnormalities,Skin,N
763,1,Headache,Headaches NEC,Headaches,Nerv,N
763,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
764,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
764,2,Incorrect dose administered by product,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
764,3,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
765,1,Atrioventricular block first degree,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
765,2,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
766,1,Acute generalised exanthematous pustulosis,Pustular conditions,Epidermal and dermal conditions,Skin,N
767,1,Arrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
767,2,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
768,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
768,2,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
769,1,Product container issue,Product packaging issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
769,2,Product container seal issue,Product packaging issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
770,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
771,1,Skin cancer,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
772,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
772,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
772,3,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
773,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
773,2,Dementia with Lewy bodies,Dementia (excl Alzheimer's type),Mental impairment disorders,Nerv,N
773,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
773,4,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
773,5,Parkinson's disease,Parkinson's disease and parkinsonism,Movement disorders (incl parkinsonism),Nerv,N
774,1,Neuroleptic malignant syndrome,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
774,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
775,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
775,2,Neuroleptic malignant syndrome,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
775,3,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
775,4,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
776,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
776,2,Neuroleptic malignant syndrome,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
776,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
777,1,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
777,2,Product physical issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
777,3,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
778,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
779,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
780,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
780,2,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
780,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
781,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
782,1,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
782,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
782,3,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
782,4,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
782,5,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
782,6,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
782,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
782,8,Quality of life decreased,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
782,9,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
783,1,Aphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
783,2,Bradykinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
783,3,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
784,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
784,2,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
784,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
785,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
785,2,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
786,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
787,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
787,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
787,3,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
788,1,Dementia,Dementia (excl Alzheimer's type),Mental impairment disorders,Nerv,N
789,1,Dementia with Lewy bodies,Dementia (excl Alzheimer's type),Mental impairment disorders,Nerv,N
790,1,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
790,2,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
791,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
791,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
791,3,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
791,4,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
791,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
792,1,Essential tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
793,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
794,1,Movement disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
795,1,Ageusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
796,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
797,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
798,1,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
798,2,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
799,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
800,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
800,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
800,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
801,1,Catatonia,Decreased physical activity levels,Changes in physical activity,Psych,N
801,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
802,1,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
802,2,Intentional removal of drug delivery system by patient,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
803,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
803,2,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
803,3,Product design issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
804,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
804,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
804,3,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
804,4,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
805,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
805,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
805,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
806,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
806,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
807,1,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
807,2,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
808,1,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
808,2,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
808,3,Skin abrasion,Skin injuries NEC,Injuries NEC,Inj&P,N
809,1,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
810,1,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
810,2,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
811,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
812,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
813,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
813,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
814,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
814,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
814,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
815,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
815,2,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
815,3,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
815,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
816,1,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
817,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
818,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
819,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
820,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
820,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
820,3,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
820,4,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
820,5,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
820,6,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
820,7,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
821,1,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
821,2,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
821,3,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
822,1,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
823,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
823,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
824,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
824,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
824,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
825,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
826,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
826,2,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
827,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
827,2,Product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
827,3,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
827,4,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
828,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
828,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
829,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
830,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
830,2,Learning disability,Learning disorders,Cognitive and attention disorders and disturbances,Psych,N
831,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
832,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
833,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
834,1,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
835,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
836,1,Delirium,Deliria,Deliria (incl confusion),Psych,N
836,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
837,1,Product residue present,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
837,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
837,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
837,4,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
838,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
839,1,Dementia Alzheimer's type,Alzheimer's disease (incl subtypes),Mental impairment disorders,Nerv,N
839,2,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
840,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
840,2,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
840,3,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
840,4,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
841,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
842,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
843,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
844,1,Abdominal pain lower,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
844,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
845,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
846,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
846,2,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
847,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
847,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
847,3,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
848,1,Dementia,Dementia (excl Alzheimer's type),Mental impairment disorders,Nerv,N
848,2,Trismus,Muscle tone abnormalities,Muscle disorders,Musc,N
849,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
849,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
849,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
849,4,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
849,5,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
850,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
850,2,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
850,3,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
851,1,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
851,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
852,1,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
852,2,Middle insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
852,3,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
853,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
854,1,Tendon disorder,Tendon disorders,"Tendon, ligament and cartilage disorders",Musc,N
855,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
856,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
856,2,Headache,Headaches NEC,Headaches,Nerv,N
856,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
856,4,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
857,1,Delirium,Deliria,Deliria (incl confusion),Psych,N
857,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
858,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
858,2,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
859,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
860,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
860,2,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
861,1,Circumstance or information capable of leading to medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
861,2,Product complaint,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
862,1,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
863,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
863,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
863,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
863,4,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
864,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
864,2,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
864,3,Skin erosion,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
865,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
865,2,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
866,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
867,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
867,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
867,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
867,4,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
868,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
869,1,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
869,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
870,1,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
871,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
871,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
871,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
871,4,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
872,1,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
